Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Correction for Lombardi et al., Arterioscler Thromb Vasc Biol 28 (4) 718-724.
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:e150
doi: 10.1161/ATVBAHA.107.654321
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:e150.)
© 2008 American Heart Association, Inc.

Correction

In the article "A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-{alpha} and Interferon-{gamma} Inflammatory Effects in Human Endothelial Cells" by Cantini et al, which appeared in the April 2008 issue of the journal (Arterioscler Thromb Vasc Biol. 2008;28:718–724), Figure 2B was inadvertently published as black and white instead of color. The revised figure is below.


Figure 2
View larger version (15K):
[in this window]
[in a new window]

 
Figure 2B.

The publisher regrets this error.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions